MHRA Extends Licence for Blincyto: What It Means for ALL Patients🪪
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for Amgen’s Blincyto (blinatumomab), expanding…
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for Amgen’s Blincyto (blinatumomab), expanding…